You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Creation Date2019-07-14 16:16:01 UTC
Last Updated2019-10-01 21:37:10 UTC
CypComp IDCC00032
Compound Information
Structure ImageJlrgjrbpoggcbt uhfffaoysa n
PubChem ID5505
CypCompound Information
SetCypReact Training Set
Reactant Statuses
  1. Komatsu K, Ito K, Nakajima Y, Kanamitsu Si, Imaoka S, Funae Y, Green CE, Tyson CA, Shimada N, Sugiyama Y: Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments. Drug Metab Dispos. 2000 Apr;28(4):475-81. [PubMed:10725317 ]
  2. Veronese ME, Mackenzie PI, Doecke CJ, McManus ME, Miners JO, Birkett DJ: Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1112-8. doi: 10.1016/0006-291x(91)91680-b. [PubMed:2025243 ]
  3. Wester MR, Lasker JM, Johnson EF, Raucy JL: CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Drug Metab Dispos. 2000 Mar;28(3):354-9. [PubMed:10681382 ]
Download FileCC00032.sdf